Cargando…

Severe varicose veins and the risk of mortality: a nationwide population-based cohort study

OBJECTIVE: Varicose veins (VVs) are common and although considered benign may cause morbidity. However, the association between VV severity and cardiovascular and mortality risks remains unknown. The aim of this study was to investigate the factors associated with overall mortality in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Nan-Chun, Chen, Zhih-Cherng, Feng, I-Jung, Ho, Chung-Han, Chiang, Chun-Yen, Wang, Jhi-Joung, Chang, Wei-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311034/
https://www.ncbi.nlm.nih.gov/pubmed/32565451
http://dx.doi.org/10.1136/bmjopen-2019-034245
_version_ 1783549482602856448
author Wu, Nan-Chun
Chen, Zhih-Cherng
Feng, I-Jung
Ho, Chung-Han
Chiang, Chun-Yen
Wang, Jhi-Joung
Chang, Wei-Ting
author_facet Wu, Nan-Chun
Chen, Zhih-Cherng
Feng, I-Jung
Ho, Chung-Han
Chiang, Chun-Yen
Wang, Jhi-Joung
Chang, Wei-Ting
author_sort Wu, Nan-Chun
collection PubMed
description OBJECTIVE: Varicose veins (VVs) are common and although considered benign may cause morbidity. However, the association between VV severity and cardiovascular and mortality risks remains unknown. The aim of this study was to investigate the factors associated with overall mortality in patients with VV. METHODS: A total of 4644 patients with newly diagnosed VV between 1999 and 2013 were identified from Taiwan’s National Health Insurance Database. VV severity was classified from grade 1 to 3 according to the presentation of ulcers or inflammation. Moreover, 9497, 2541 and 5722 age-matched, sex-matched and chronic cardiovascular risk factor-matched controls, as assessed based on propensity score, were separately selected for three grading VV groups. Enrolled patients were analysed using conditional Cox proportional hazards regression analysis to estimate risk of mortality and major adverse cardiovascular events (MACEs) in the VV and control groups. RESULTS: Most patients with VV were free from systemic disease. However, compared with matched controls, patients with VV showed a 1.37 times increased risk of mortality (95% CI 1.19 to 1.57; p<0.0001). Compared with matched controls, older (age ≧65 years) (adjusted HR: 1.38; 95% CI 1.17 to 1.62; p=0.0001) and male patients with VV (adjusted HR 1.41; 95% CI 1.18 to 1.68; p=0.0001) showed increased risk of mortality. Furthermore, compared with controls, patients with VV showed 2.05 times greater risk of MACE. Compared with matched controls, population at grade 3 increased 1.83 times risk of mortality and 2.04 to 38.42 times risk of heart failure, acute coronary syndrome, ischaemic stroke and venous thromboembolism. CONCLUSIONS: This nationwide cohort study demonstrated that patients with VV are at a risk of cardiovascular events and mortality. Our findings suggest that presence of VV warrants close attention in terms of prognosis and treatment.
format Online
Article
Text
id pubmed-7311034
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-73110342020-06-26 Severe varicose veins and the risk of mortality: a nationwide population-based cohort study Wu, Nan-Chun Chen, Zhih-Cherng Feng, I-Jung Ho, Chung-Han Chiang, Chun-Yen Wang, Jhi-Joung Chang, Wei-Ting BMJ Open Cardiovascular Medicine OBJECTIVE: Varicose veins (VVs) are common and although considered benign may cause morbidity. However, the association between VV severity and cardiovascular and mortality risks remains unknown. The aim of this study was to investigate the factors associated with overall mortality in patients with VV. METHODS: A total of 4644 patients with newly diagnosed VV between 1999 and 2013 were identified from Taiwan’s National Health Insurance Database. VV severity was classified from grade 1 to 3 according to the presentation of ulcers or inflammation. Moreover, 9497, 2541 and 5722 age-matched, sex-matched and chronic cardiovascular risk factor-matched controls, as assessed based on propensity score, were separately selected for three grading VV groups. Enrolled patients were analysed using conditional Cox proportional hazards regression analysis to estimate risk of mortality and major adverse cardiovascular events (MACEs) in the VV and control groups. RESULTS: Most patients with VV were free from systemic disease. However, compared with matched controls, patients with VV showed a 1.37 times increased risk of mortality (95% CI 1.19 to 1.57; p<0.0001). Compared with matched controls, older (age ≧65 years) (adjusted HR: 1.38; 95% CI 1.17 to 1.62; p=0.0001) and male patients with VV (adjusted HR 1.41; 95% CI 1.18 to 1.68; p=0.0001) showed increased risk of mortality. Furthermore, compared with controls, patients with VV showed 2.05 times greater risk of MACE. Compared with matched controls, population at grade 3 increased 1.83 times risk of mortality and 2.04 to 38.42 times risk of heart failure, acute coronary syndrome, ischaemic stroke and venous thromboembolism. CONCLUSIONS: This nationwide cohort study demonstrated that patients with VV are at a risk of cardiovascular events and mortality. Our findings suggest that presence of VV warrants close attention in terms of prognosis and treatment. BMJ Publishing Group 2020-06-21 /pmc/articles/PMC7311034/ /pubmed/32565451 http://dx.doi.org/10.1136/bmjopen-2019-034245 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Cardiovascular Medicine
Wu, Nan-Chun
Chen, Zhih-Cherng
Feng, I-Jung
Ho, Chung-Han
Chiang, Chun-Yen
Wang, Jhi-Joung
Chang, Wei-Ting
Severe varicose veins and the risk of mortality: a nationwide population-based cohort study
title Severe varicose veins and the risk of mortality: a nationwide population-based cohort study
title_full Severe varicose veins and the risk of mortality: a nationwide population-based cohort study
title_fullStr Severe varicose veins and the risk of mortality: a nationwide population-based cohort study
title_full_unstemmed Severe varicose veins and the risk of mortality: a nationwide population-based cohort study
title_short Severe varicose veins and the risk of mortality: a nationwide population-based cohort study
title_sort severe varicose veins and the risk of mortality: a nationwide population-based cohort study
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311034/
https://www.ncbi.nlm.nih.gov/pubmed/32565451
http://dx.doi.org/10.1136/bmjopen-2019-034245
work_keys_str_mv AT wunanchun severevaricoseveinsandtheriskofmortalityanationwidepopulationbasedcohortstudy
AT chenzhihcherng severevaricoseveinsandtheriskofmortalityanationwidepopulationbasedcohortstudy
AT fengijung severevaricoseveinsandtheriskofmortalityanationwidepopulationbasedcohortstudy
AT hochunghan severevaricoseveinsandtheriskofmortalityanationwidepopulationbasedcohortstudy
AT chiangchunyen severevaricoseveinsandtheriskofmortalityanationwidepopulationbasedcohortstudy
AT wangjhijoung severevaricoseveinsandtheriskofmortalityanationwidepopulationbasedcohortstudy
AT changweiting severevaricoseveinsandtheriskofmortalityanationwidepopulationbasedcohortstudy